日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.

靶向芳烃受体以减弱甲状腺眼病中的IGF1R信号传导

Roztocil Elisa, Husain Farha, Patrick Charkira C, Feldon Steven E, Woeller Collynn F

OR31-06 Lonigutamab (Anti-IGF-1R Monoclonal Antibody) Induces Efficient Degradation of IGF-1R in Thyroid Eye Disease Orbital Fibroblasts

OR31-06 Lonigutamab(抗IGF-1R单克隆抗体)可有效降解甲状腺眼病眼眶成纤维细胞中的IGF-1R

Van Eijgen, Jan; Schuhmann, Valentin; Fingerroos, Emma-Liina; Renier, Marie; Burchert, Holger; Kröpfl, Julia Maria; Van Craenenbroeck, Amaryllis; Cornelissen, Véronique; Gugleta, Konstantin; Stalmans, Ingeborg; Hanssen, Henner; Welch, Brett; Roztocil, Elisa; Husain, Farha; Feldon, Steven E; Nyborg, Andrew; Mpofu, Shephard; Woeller, Collynn F

MON-360 Lonigutamab (Anti-IGF-1R Monoclonal Antibody) Reduces IGF-1-Mediated Hyaluronan Production in Thyroid Eye Disease Orbital Fibroblasts

MON-360 Lonigutamab(抗IGF-1R单克隆抗体)可降低甲状腺眼病眼眶成纤维细胞中IGF-1介导的透明质酸生成

Serhan, Hashem Abu; Alma'aitah, Huthaifa W; Irshaidat, Sara; Ameer, Muhammad Atif; Asghar, Muhammad Sohaib; Tahir, Muhammad Junaid; Nyborg, Andrew; Roztocil, Elisa; Husain, Farha; Feldon, Steven E; Welch, Brett; Mpofu, Shephard; Woeller, Collynn F

Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel Therapy

Tapinarof(一种芳烃受体配体)可减轻甲状腺眼病中的成纤维细胞活化:对新型疗法的启示

Patrick, Charkira C; Roztocil, Elisa; Husain, Farha; Feldon, Steven E; Woeller, Collynn F

The Answer is "No": A Comment on Peugh and Feldon (2020)

答案是“否”:对Peugh和Feldon(2020)的评论

Peugh, James L; Feldon, David F

Vision-related quality of life after unilateral occipital stroke

单侧枕叶卒中后视觉相关生活质量

Dogra, Neil; Redmond, Bryan V; Lilley, Selena; Johnson, Brent A; Lam, Byron L; Tamhankar, Madhura; Feldon, Steven E; Fahrenthold, Berkeley; Yang, Jingyi; Huxlin, Krystel R; Cavanaugh, Matthew R

Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease

针对甲状腺眼病的FcRn抑制剂Batoclimab的概念验证和随机、安慰剂对照试验

Kahaly, George J; Dolman, Peter J; Wolf, Jan; Giers, Bert C; Elflein, Heike M; Jain, Amy P; Srinivasan, Ashok; Hadjiiski, Lubomir; Jordan, David; Bradley, Elizabeth A; Stan, Marius N; Eckstein, Anja; Pitz, Susanne; Vorländer, Christian; Wester, Sara T; Nguyen, John; Tucker, Nancy; Sales-Sanz, Marco; Feldon, Steven E; Nelson, Christine C; Hardy, Isabelle; Abia-Serrano, Maravillas; Tedeschi, Philip; Janes, Jonathan M; Xu, Jing; Vue, Peter; Macias, William L; Douglas, Raymond S

1985. A Prospective, Randomized Trial to Assess a Protease Inhibitor–based Regimen Switch Strategy to Manage Integrase Inhibitor–related Weight Gain

1985年。一项前瞻性随机试验,旨在评估基于蛋白酶抑制剂的方案转换策略在控制整合酶抑制剂相关体重增加方面的疗效。

Serna-Galvis, Efraím A; Arboleda-Echavarría, Johana; Echavarría-Isaza, Adriana; Torres-Palma, Ricardo A; Coutinho, Eulalia A; Fowler, Melissa A; Regan, Collin; Zhao, Jian; Fleck, Beth A; Boekell, Kimber; Tang, Yang; Rico-Bautista, Elizabeth; Woeller, Collynn F; Feldon, Steven E; Dalvie, Deepak; Betz, Stephen F; Bakker, T R; Briasoulis, O; Olivieri, A; Pain, S; Palagini, L; Kunz, D; Geoffroy, P-A; Daigle, Denis; Hamrick, Jodie; Chatwin, Cassandra; Kurepina, Natalia; Kreiswirth, Barry N; Shields, Ryan K; Oliver, Antonio; Clancy, Cornelius J; Nguyen, Minh-Hong; Pevear, Daniel; Xerri, Luigi; Short, William R; Ramgopal, Moti; Hagins, Debbie P; Lee, Johnnie; Bruce Simonson, Richard; Hsu, Tien-Huei; Xu, Ping; Anderson, David

43. Trends in Craniofacial Fellowship Career Outcomes: A Call for Expanding Professional Opportunities in Craniofacial Surgery

43.颅面外科专科医师职业发展趋势:呼吁扩大颅面外科领域的职业机会

Douglas, Raymond S; Tsirbas, Angelo; Gordon, Mark; Lee, Diana; Khadavi, Nicole; Garneau, Helene Chokron; Goldberg, Robert A; Cahill, Kenneth; Dolman, Peter J; Elner, Victor; Feldon, Steve; Lucarelli, Mark; Uddin, Jimmy; Kazim, Michael; Smith, Terry J; Khanna, Dinesh; Mukherjee, Hrijeeta; Ellor, Molly; Shankar, Sushma; Davison, Steven; Rogers, Ashley E; Sayyed, Adaah A; Marable, Julian; Harshbarger, Raymond III; Taub, Peter J; Taylor, Jesse; Baker, Stephen B

More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease

远不止表面所见:芳烃受体既是环境传感器,又是生理调节器,还是眼科疾病的治疗靶点

Hammond, Christine L; Roztocil, Elisa; Gupta, Vardaan; Feldon, Steven E; Woeller, Collynn F